Shenzhen Main Luck Pharmaceuticals Inc.

A joint venture of China,Japan and Hongkong China.It dedicates to research and development, manufacturing, marketing and distribution of medicines for cancer treatment, manufactures antineoplastic including Docetaxel Injection,Paclitaxel Injection,Pirarubicin Hydrochloride for Injection,Vinorelbine Tartrate for Injection,Ubenimex Tablets etc. We Looking for agents in Southeast Asia or South America. [详细介绍]